HealthLynked Corp. Reports Full Year 2018 Results with 7% increase in Revenue

NEXT STORY
Global Kinetics Corporation Appoints Greg Barrett As Independent Director to its Board of Directors
PREV STORY
Expanded MS1819-SD Global Commercialization Rights Now Owned by AzurRx BioPharma along with Full Development Rights
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Flexion Therapeutics Submits Supplemental New Drug Application (sNDA) for ZILRETTA® (triamcinolone acetonide extended-release injectable suspension)

sNDA aims to revise the product label with new data indicating repeat administration of ...

author_avatar
NASDAQ Market News

NetworkNewsWire Announces Publication on Innovative Approaches in Non-Addictive Analgesics

NEW YORK, Feb. 02, 2018 (GLOBE NEWSWIRE) -- via NetworkWire — NetworkNewsWire ("NNW"), a ...

author_avatar
NASDAQ Market News

Generex Biotechnology Announces First Patient Enrolled in the Phase II Clinical Trial of AE37 in Combination with Pembrolizumab (KeytrudaÒ) for the Treatment of Triple Negative Breast Cancer

author_avatar
NASDAQ Market News